Uncomplicated Essential Hypertension Therapeutics
1. Bystolic patent expiration
Treatment: Treatment of hypertension
BYSTOLIC IPR and PTAB Proceedings
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6545040 | ALLERGAN | Method of lowering the blood pressure |
Dec, 2021
(4 years ago) | |
| US5759580 | ALLERGAN | Compositions containing micronized nebivolol |
Jun, 2015
(10 years ago) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| New Chemical Entity Exclusivity(NCE) | Dec 17, 2012 |
Drugs and Companies using NEBIVOLOL HYDROCHLORIDE ingredient
NCE-1 date: 18 December, 2011
Market Authorisation Date: 17 December, 2007
Dosage: TABLET
How can I launch a generic of BYSTOLIC before it's drug patent expiration?
More Information on Dosage
BYSTOLIC family patents
